Wednesday, July 11, 2012

Avinger Gains $33M In Series D

Redwood City-based Avinger, a developer of medical devices used for treating peripheral artery disease (PAD), said yesterday that it has raised $33M in a Series D funding round. The firm said its existing major investors participated in the round, with new investors contributing $11M towards the effort. Names of those various investors were not announced by the company. Avinger said it will use the funds for research and development. The company was advised by JMP Securities in the deal. More information »